From Health Canada:
Eli Lilly Canada, after consultation with Health Canada, would like to bring to your attention important safety information concerning ACTOS® (pioglitazone hydrochloride) tablets, used in the treatment of type 2 diabetes mellitus and the occurrence of bone fractures in female patients.
For health professionals
For the public
Wednesday, May 09, 2007
Association between Long-Term Treatment with ACTOS® (pioglitazone hydrochloride) Tablets for Type 2 Diabetes Mellitus and Fractures in Women
Labels:
Actos,
diabetes,
Health Canada warning,
pioglitazone
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment